AACR Washington DC, April 6-10, 2013
Posted by Che Chen on
On April 8th, Vitatex and Stonybrook Medicine will present Late-Breaking Research poster abstract #9095 "Circulating Tumor Cells with the Invasive Phenotype Predict Progression-free Survival and Overall Survival in Preoperative Patients Diagnosed with Advanced Epithelial Ovarian Cancer" which describes robust prognosis of preoperative patients for advanced epithelial ovarian cancer that could help tailor appropriate therapy. "In Vitro Production of Circulating Tumor Cells (CTCs) Using 3D Cultures of Human Tissues and Established Tumor Cells Lines" by William P. Fund, George Martin and Paul A. Neeb, of Realbio Technology and Roche Molecular Systems, Inc, features Vitatex's Vita-Assay technology.
← Older Post Newer Post →